FM
LLY icon

Foster & Motley’s Eli Lilly LLY Stock Holding History

Foster & Motley’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$977K Sell
814
-6
-0.7% -$6.13K 0.05% 237
2026
Q1 		$754K Sell
820
-16
-2% -$16.2K 0.04% 261
2025
Q4 		$898K Sell
836
-4
-0.5% -$3.83K 0.05% 241
2025
Q3 		$641K Sell
840
-118
-12% -$87.8K 0.03% 270
2025
Q2 		$747K Buy
958
+68
+8% +$52.8K 0.04% 248
2025
Q1 		$735K Sell
890
-666
-43% -$554K 0.05% 244
2024
Q4 		$1.2M Buy
1,556
+584
+60% +$484K 0.08% 202
2024
Q3 		$861K Sell
972
-150
-13% -$135K 0.05% 225
2024
Q2 		$1.02M Buy
1,122
+48
+4% +$38.4K 0.07% 199
2024
Q1 		$836K Buy
1,074
+129
+14% +$91.8K 0.06% 222
2023
Q4 		$551K Sell
945
-63
-6% -$36.8K 0.04% 252
2023
Q3 		$541K Sell
1,008
-83
-8% -$42.8K 0.04% 258
2023
Q2 		$512K Buy
+1,091
New +$458K 0.04% 282
2022
Q2 		– Sell
-2,243
Closed -$642K – 368
2022
Q1 		$642K Buy
+2,243
New +$577K 0.05% 240

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Foster & Motley's LLY Position: Q2 2026 in Review

Foster & Motley reduced its Eli Lilly (LLY) stake by 0.73% in Q2 2026, selling an estimated $6.13K and leaving 814 shares worth $977K. The position accounts for 0.05% of the portfolio, ranked #237.

Foster & Motley first reported a position in LLY in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.2M in Q4 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Foster & Motley held 814 shares of Eli Lilly worth $977K as of Q2 2026.
  • Foster & Motley sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
  • Eli Lilly made up 0.05% of Foster & Motley's portfolio in Q2 2026, its #237 holding.
  • Foster & Motley first reported a position in Eli Lilly in Q1 2022 and has held it in 14 quarters since.
  • Foster & Motley's Eli Lilly position peaked at $1.2M in Q4 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Foster & Motley's 13F filing for Q2 2026, filed 7 Aug 2026.